BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21387303)

  • 1. Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy.
    Mego M; Mani SA; Lee BN; Li C; Evans KW; Cohen EN; Gao H; Jackson SA; Giordano A; Hortobagyi GN; Cristofanilli M; Lucci A; Reuben JM
    Int J Cancer; 2012 Feb; 130(4):808-16. PubMed ID: 21387303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
    Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer.
    Mego M; Karaba M; Minarik G; Benca J; Silvia J; Sedlackova T; Manasova D; Kalavska K; Pindak D; Cristofanilli M; Reuben JM; Mardiak J
    Anticancer Res; 2019 Apr; 39(4):1829-1837. PubMed ID: 30952723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
    Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
    Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.
    Kallergi G; Papadaki MA; Politaki E; Mavroudis D; Georgoulias V; Agelaki S
    Breast Cancer Res; 2011 Jun; 13(3):R59. PubMed ID: 21663619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of EMT Markers SLUG and TWIST in Breast Cancer.
    Grzegrzolka J; Biala M; Wojtyra P; Kobierzycki C; Olbromski M; Gomulkiewicz A; Piotrowska A; Rys J; Podhorska-Okolow M; Dziegiel P
    Anticancer Res; 2015 Jul; 35(7):3961-8. PubMed ID: 26124343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Epithelial-to-Mesenchymal Transition Markers in Different Stages of Endometriosis: Expression of the Snail, Slug, ZEB1, and Twist Genes.
    Kazmi I; Alharbi KS; Al-Abbasi FA; Almalki WH; G SK; Yasmeen A; Khan A; Gupta G
    Crit Rev Eukaryot Gene Expr; 2021; 31(2):89-95. PubMed ID: 34347983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.
    Taube JH; Herschkowitz JI; Komurov K; Zhou AY; Gupta S; Yang J; Hartwell K; Onder TT; Gupta PB; Evans KW; Hollier BG; Ram PT; Lander ES; Rosen JM; Weinberg RA; Mani SA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15449-54. PubMed ID: 20713713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer.
    Cierna Z; Mego M; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Cingelova S; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2014 Jun; 14():472. PubMed ID: 24972610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial‑mesenchymal transition was identified as a potential marker for breast cancer aggressiveness using reverse transcription‑quantitative polymerase chain reaction.
    Andergassen U; Schlenk K; Jeschke U; Sommer H; Kölbl A
    Mol Med Rep; 2018 Aug; 18(2):1733-1739. PubMed ID: 29845200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
    Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
    Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
    Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
    Oncotarget; 2015 Jan; 6(2):979-94. PubMed ID: 25460509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis.
    Ji X; Lu H; Zhou Q; Luo K
    Elife; 2014 Jul; 3():e02907. PubMed ID: 25053741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
    Imani S; Hosseinifard H; Cheng J; Wei C; Fu J
    Sci Rep; 2016 Jun; 6():28587. PubMed ID: 27335258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition.
    Dave N; Guaita-Esteruelas S; Gutarra S; Frias À; Beltran M; Peiró S; de Herreros AG
    J Biol Chem; 2011 Apr; 286(14):12024-32. PubMed ID: 21317430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis.
    Proestling K; Birner P; Gamperl S; Nirtl N; Marton E; Yerlikaya G; Wenzl R; Streubel B; Husslein H
    Reprod Biol Endocrinol; 2015 Jul; 13():75. PubMed ID: 26198055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
    Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
    Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.